Melanoma

Melanoma, the most serious type of skin cancer, develops in the cells (melanocytes) that produce melanin – the pigment that gives skin its color. It can also occur in the eyes and, rarely, inside the body, such as in the nose or throat. Reducing exposure to UV radiation can help lower the risk of melanoma. The risk of melanoma seems to increase in people over 40, and especially in women.

Showing 1–12 of 20 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
IL-2RB
Recombinant protein
Proleukin®
1,1 mg/mL
0,022 mg
-80°C
07/2021
738,00 
view product
Max: 1
Min: 1
Step: 1
IL-2RB
Recombinant protein
Proleukin®
1,1 mg/mL
0,088 mg
-80°C
03/2024
778,00 
view product
Max: 10
Min: 1
Step: 1
IL-2RB
Recombinant protein
Proleukin®
1,1 mg/mL
0,044 mg
-80°C
07/2024
417,00 
view product
Max: 10
Min: 1
Step: 1
CTLA-4
Monoclonal Antibody
Yervoy®
5 mg/mL
yes
2 mg
-80°C
09/2024
952,00 
view product
Max: 10
Min: 1
Step: 1
CTLA-4
Monoclonal Antibody
Yervoy®
5 mg/mL
yes
2 mg
-80°C
08/2021
1.190,00 
view product
Max: 3
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2024
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2018
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
10/2018
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
02/2018
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
05/2019
390,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
01/2019
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
09/2020
338,00 
view product
Max: 8
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
11/2020
270,00 
view product
Max: 10
Min: 2
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
02/2021
405,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2018
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
12/2018
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
03/2019
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2019
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
yes
2 mg
-80°C
04/2022
841,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
11/2022
952,80 
view product
Max: 10
Min: 1
Step: 1

Not looking for Melanoma?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

we are recruiting